# Oruka Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Sep 19, 2025

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: SCHEDULE 13D/A
- Filed: 2025-09-19
- Accepted by EDGAR: Sep 19, 2025, 18:56 ET
- Period: not reported
- Accession: 0001104659-25-091774
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000110465925091774/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000110465925091774/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000110465925091774/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-091774. Last ingested by Listed: Nov 15, 2026, 02:43 ET. No prices; not investment advice.
